Retraction: Lin et al. miR-1 inhibits migration of gastric cancer cells. Frontiers in Bioscience (Landmark Edition). 2020; 25: 452–462

The Editor-in-Chief has retracted the article entitled “miR-1 inhibits migration of gastric cancer cells” [1] due to significant concerns regarding the reliability and integrity of the data presented.

Recently, several issues were brought to the attention of the Publisher and Editor-in-Chief regarding the originality and authenticity of the images in this paper published in 2020 prior to the present publisher and EiC taking over the management of the journal. The content of repeated figures includes but is not limited to:

(1) Fig. 2B contains images that are identical to those in Fig. 3A of a previously published paper [2].

(2) Fig. 3A contains images that are identical to those in Fig. 3A of a previously published paper [3].

These duplications of images raise serious questions about the validity of the results and the adherence to ethical standards of research. The authors were contacted for an explanation but did not reply. Therefore, the Editor-in-Chief no longer has confidence in the research presented in this work and retracted the article.

References

[1] Lin XQ, Wu W, Chen X, Chen RP, Wu F, Chen ZF, et al. mir-1 inhibits migration of gastric cancer cells. Frontiers in Bioscience (Landmark Edition). 2020; 25: 452–462. https://doi.org/10.2741/4813.

[2] Huang Y, Wu S, Zhang Y, Wang L, Guo Y. Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial-mesenchymal transition via regulating the PI3K/AKT/mTOR pathway. OncoTargets and Therapy. 2018; 11: 769–779. https://doi.org/10.2147/OTT.S149788.

[3] Jiang X, Ding W, Shen W, Jin J. H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition. Translational Cancer Research. 2020; 9: 3915–3925. https://doi.org/10.21037/tcr-20-1736.